In addition to presentations and abstracts being delivered by Mayo Clinic staff at the upcoming 56th ASH Annual Meeting & Exposition in San Francisco, Mayo Medical Laboratories representatives will also be available at booth #2637 in the exhibit hall to discuss:
- CALR MUTATION ANALYSIS: Diagnosis and prognosis of Philadelphia chromosome-negative myeloproliferative neoplasms
- ASH SYMPOSIUM PRESENTATIONS: Data-Driven Algorithms for Optimizing Laboratory Test Utilization for Hematologic Malignancies
- AMYLOIDOSIS: Accurate subtyping for timely, effective, and cost efficient disease management.
- THROMBOTIC MICROANGIOPATHY (TMA): Facilitate prompt diagnosis and management of patients
- MULTIPLE MYELOMA: Improving Diagnosis and Treatment
- LYMPHOMA: Guiding diagnosis and treatment of a complex disease
- DIAGNOSTIC IMMUNOLOGY TESTING: Assessing immune reconstitution and immune competence post-hematopoietic cell transplantation
- SEND AND HOLD SERVICES: Cost-effective strategies for diagnosis and management of hematologic disorders
- COAGULATION DISORDER TESTING: Consultative test panels for complex or difficult diagnostic problems
CALR MUTATION ANALYSIS
The new CALR Mutation Analysis, Myeloproliferative Neoplasm (MPN) should be ordered on patients with clinical suspicion of essential thrombocythemia or primary myelofibrosis
- A Test in Focus: CALR Mutation Analysis, Myeloproliferative Neoplasm (MPN)
- Test Catalog: CALR Mutation Analysis, Myeloproliferative Neoplasm (MPN)
- Algorithm: Myeloproliferative Neoplasm - A Diagnostic Approach to Peripheral Blood Evaluation
- Algorithm: Myeloproliferative Neoplasm - A Diagnostic Approach to Bone Marrow Evaluation
At least 25 different proteins have been shown to cause amyloidosis and the underlying pathogenesis of each subtype of amyloidosis is unique. The treatment approach for each subtype of amyloidosis may be radically different. Mayo Clinic has developed a novel diagnostic methodology that can subtype amyloidosis in routine biopsy specimens with high accuracy.
- Featured Topic: Amyloidosis - Accurate Subtyping Using Novel Diagnostic Methodology
- Test Catalog: Amyloid Protein Identification, Paraffin, LC MS/MS
- Informational PDF: Amyloid Protein Identification
THROMBOTIC MICROANGIOPATHY (TMA)
Thrombotic microangiopathy is a group of disorders that is characterized by thrombocytopenia and microangiopathic hemolytic anemia (intravascular hemolysis and presence of peripheral blood schistocytes), neurological symptoms, fever, and renal dysfunction. Ischemic organ injury can occur to the brain, kidneys, heart, pancreas, liver, and lungs.
- Featured Topic: Differential Analysis for Thrombotic Microangiopathy (TMA)
- Testing Options: Tests most frequently associated with TMA
- Informational PDF: Facilitate prompt diagnosis and management of patients with TMA
The diagnosis of multiple myeloma is established by integrating the pertinent clinical, laboratory, radiologic, and pathologic data. The enumeration of plasma cells in an adequate bone marrow specimen and establishment of plasma cell clonality are the key components.
- Algorithm: Laboratory Screening Tests for Suspected Multiple Myeloma
- Featured Topic: Diagnosis of Multiple Myeloma
- Featured Topic: Prognostic Testing in Multiple Myeloma Using Cytogenetics and FISH
Lymphomas are among the most complex diseases to recognize and diagnose because they are pathologically complex, with features that overlap with reactive and inflammatory conditions and other nonhematologic malignancies. Criteria for lymphoma diagnosis rely on morphology and a variety of ancillary studies, including phenotype and genetic features.
- Featured Topic: Guiding diagnosis and treatment of a complex disease
- Algorithm: Malignant Lymphoma, Guideline for Bone Marrow Staging Studies
- Test Menu: Tests most frequently associated with lymphoma
DIAGNOSTIC IMMUNOLOGY TESTING FOR THE HEMATOLOGIST
Hematopoietic cell transplantation recalibrates every component of the hematopoietic system, in addition to resetting the clock on the immune system. Therefore, immunology testing is clinically and financially effective because it helps monitor the adequate numerical and functional recovery of the immune system.
- Featured Topic: Assessing immune reconstitution and immune competence post-hematopoietic cell transplantation
- Test Menu: Tests most frequently associated with immune monitoring and primary immunodeficiencies
COAGULATION DISORDER TESTING
The Mayo Clinic Special Coagulation Laboratory has been at the forefront of research, testing, and treatment of patients with bleeding and thrombosing disorders for nearly 90 years. From pioneering studies in thrombosis, hirudin, warfarin, and vitamin K physiology to cutting-edge platelet physiology, our reputation in the field continues to grow.